News Snapshot:
BENJAMIN BARRETT WRITES – Although vaccine manufacture and distribution continue rolling out globally, it is important, still, to research treatment options for people who already have COVID-19. One option that has come to light recently is Molnupiravir. Molnupiravir is a drug created by the pharmaceutical company Merck. Essentially, Molnupiravir is an antiviral drug, similar to Remdesivir but supposedly it works even better. According to this Nature article, the Molnupiravir pill could cut COVID-19 hospitalizations and deaths in half. How does Molnupiravir work? Unlike the vaccines, which help prevent the spread of the virus, Molnupiravir is used to treat those diagnosed...
